Comparative bioavailability of erythromycin-sulfisoxazole combinations. 1986

K A Desante, and C F Ryan, and S Wallen, and E C Heath

UI MeSH Term Description Entries
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

K A Desante, and C F Ryan, and S Wallen, and E C Heath
January 1983, MCN. The American journal of maternal child nursing,
K A Desante, and C F Ryan, and S Wallen, and E C Heath
October 1976, Journal of pharmaceutical sciences,
K A Desante, and C F Ryan, and S Wallen, and E C Heath
May 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K A Desante, and C F Ryan, and S Wallen, and E C Heath
January 1991, Journal of acquired immune deficiency syndromes,
K A Desante, and C F Ryan, and S Wallen, and E C Heath
December 1991, The Pediatric infectious disease journal,
K A Desante, and C F Ryan, and S Wallen, and E C Heath
July 1987, The Pediatric infectious disease journal,
K A Desante, and C F Ryan, and S Wallen, and E C Heath
October 1990, Lancet (London, England),
K A Desante, and C F Ryan, and S Wallen, and E C Heath
August 1973, The Medical journal of Australia,
K A Desante, and C F Ryan, and S Wallen, and E C Heath
August 1973, The Medical journal of Australia,
Copied contents to your clipboard!